ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305329 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305329; 2) Community: the network communities that were significantly associated with the response to NSC 305329; 3) Molecule: the relationships between components within communities and NSC 305329; 4) MDR: the compounds that were significantly associated with the NSC 305329.

NSC Compound Enrichment Correlation
NSC 681644 Camptothecin Derivative 0.0195559279909782 0.19833898
NSC 693326 Null 0.0195559279909782 0.38363821
NSC 700582 [1,2,3,4]tetrathiocino[5,6-d:7,8-d']diimidazole -2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0195559279909782 0.096382122
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0195559279909782 0.3417683
NSC 732661 6-(3-Chloropropyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]i soquinoline 0.0195559279909782 0.31978077
NSC 744449 Null 0.0195559279909782 0.12705954
NSC 112965 Null 0.0195559279909783 0.317644
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.0195559279909783 0.25642848
NSC 329086 MITOMYCIN C,METHYLAMINE FR. STREPTOMYCES CAESPITOSUS 0.0237952199154252 0.069688571
NSC 619031 Analog of CC-1065 0.0237952199154252 0.086275435
Total:24  Current:7    [First] [Prev] [Next] [Last]